Skip to main content
. 2007 Nov-Dec;55(6):460–462. doi: 10.4103/0301-4738.36484

Figure 1.

Figure 1

(A) Slit-lamp photograph showing circumcorneal congestion and neovascularization over the iris and lens capsule (Black arrow); (B and C) Photographs showing the total regression of neovascularization one week and six months respectively following intracameral injection of bevacizumab (Avastin)